According to a new report, published by KBV research, The Global Vascular Access Device Market size is expected to reach $9 billion by 2030, rising at a market growth of 7.2% CAGR during the forecast period.
The Blood Transfusion segment is registering a CAGR of 8.1% during (2023 - 2030). Vascular access devices are essential in blood transfusions because they offer a quick and easy means to inject blood products directly into the patient's bloodstream, obviating the need for many needle sticks and enhancing patient comfort.
The Hospital segment is leading the Global Vascular Access Device Market by End User in; thereby, achieving a market value of $4.8 billion by 2030. The segment will probably be able to maintain its dominance during the forecast period due to the wide availability of highly qualified and experienced healthcare personnel in hospitals. The presence of qualified and experienced staff provides the finest service and enhanced vascular access outcomes in healthcare institutions, including dialysis clinics and hospitals.
The Peripheral Vascular Access Device segment would register a CAGR of 7.3% during (2023 - 2030). A PICC line is a long, extremely thin, flexible catheter, and often inserted into a large vein in the arm with only a small section of the tube and an injection cap emerging from the skin. It is fastened to the skin using staples, an internal fastener, or an adhesive device. A sizeable vein connects to this tube on the right side of the chest, just above the heart.
The North America region dominated the Global Vascular Access Device Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3.1 billion by 2030. The Europe market is poised to grow at a CAGR of 7% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 7.9% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/vascular-access-device-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ICU Medical, Inc., Teleflex, Inc., B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Edwards Lifesciences Corporation, Nipro Corporation and Romsons
By Application
By End User
By Type
By Geography
Companies Profiled
Unique Offerings 
